{"database": "openregs", "table": "documents", "rows": [["FDA-2005-P-0381-0005", "FDA", "FDA-2005-P-0381", "Attachment 2 - Product Description for Diphenoxylate Hydrochloride and Atropin Sulfate Tablets and Oral Solution, 5 mg/0.05 mg re Citizens Petition from Lachman Consultant Services, Inc.", "Supporting & Related Material", "Background Material", "2008-12-30T05:00:00Z", 2008, 12, null, null, "2024-11-12T17:56:32Z", null, 0, 0, "09000064807ddd58"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2005-P-0381-0005"], "units": {}, "query_ms": 0.4192609339952469, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}